Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Syncona Shs GBP ( (GB:SYNC) ) just unveiled an update.
Syncona Limited has announced the purchase of 500,000 of its own ordinary shares at a price of 101.40 GBp each, as part of its ongoing share buyback program. These shares will be held in treasury, impacting the total voting rights in the company, which now stand at 625,308,994. This transaction supports Syncona’s strategy of maintaining a strong balance sheet to enable long-term investments and risk-adjusted returns for shareholders.
More about Syncona Shs GBP
Syncona is a leading life science investor dedicated to creating, building, and scaling a portfolio of global leaders in the life sciences sector. The company focuses on developing transformational treatments for patients with high unmet medical needs by partnering with world-class academic founders and experienced management teams. Syncona aims to build a diversified portfolio of 20-25 globally leading life science businesses across various development stages, modalities, and therapeutic areas.
YTD Price Performance: -2.46%
Average Trading Volume: 709,384
Technical Sentiment Consensus Rating: Buy
Learn more about SYNC stock on TipRanks’ Stock Analysis page.
